Eric Tardif
Founder bij Maravai Life Sciences, Inc.
Profiel
Eric Tardif richtte Maravai Lifesciences Holdings, Inc. en Maravai Life Sciences, Inc. op. De heer Tardif bekleedt de functie van President voor Vector Laboratories, Inc., President & Partner bij Maravai Life Sciences, Inc. en President van Maravai Lifesciences Holdings, Inc. Eric Tardif was voorheen Senior Vice President-Corporate Strategy bij Hologic, Inc. en Senior VP-Corporate Development & Marketing bij Gen-Probe, Inc. (een dochteronderneming van Hologic, Inc.). Hij behaalde een bachelor aan Bishop's University, een MBA aan de University of British Columbia en een graduaat aan Boston College.
Actieve functies van Eric Tardif
Bedrijven | Functie | Begin |
---|---|---|
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Founder | 18-03-2014 |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | President | - |
Eerdere bekende functies van Eric Tardif
Bedrijven | Functie | Einde |
---|---|---|
MARAVAI LIFESCIENCES HOLDINGS, INC. | Founder | 30-06-2021 |
HOLOGIC, INC. | Corporate Officer/Principal | - |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 18-10-2011 |
Opleiding van Eric Tardif
Boston College | Graduate Degree |
University of British Columbia | Masters Business Admin |
Bishop's University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
HOLOGIC, INC. | Health Technology |
MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | Process Industries |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Finance |